GB931137A - A method of producing canine distemper vaccine - Google Patents

A method of producing canine distemper vaccine

Info

Publication number
GB931137A
GB931137A GB30150/59A GB3015059A GB931137A GB 931137 A GB931137 A GB 931137A GB 30150/59 A GB30150/59 A GB 30150/59A GB 3015059 A GB3015059 A GB 3015059A GB 931137 A GB931137 A GB 931137A
Authority
GB
United Kingdom
Prior art keywords
virus
culture
fluid
culture fluid
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB30150/59A
Other languages
English (en)
Inventor
Karl Gunnar Leonard Rockborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to GB30150/59A priority Critical patent/GB931137A/en
Priority to CH983060A priority patent/CH402283A/de
Priority to LU39127D priority patent/LU39127A1/xx
Priority to BE594749A priority patent/BE594749A/fr
Publication of GB931137A publication Critical patent/GB931137A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18461—Methods of inactivation or attenuation
    • C12N2760/18464—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB30150/59A 1959-09-03 1959-09-03 A method of producing canine distemper vaccine Expired GB931137A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB30150/59A GB931137A (en) 1959-09-03 1959-09-03 A method of producing canine distemper vaccine
CH983060A CH402283A (de) 1959-09-03 1960-08-31 Verfahren zur Herstellung einer Vaccine gegen Staupe
LU39127D LU39127A1 (de) 1959-09-03 1960-09-01
BE594749A BE594749A (fr) 1959-09-03 1960-09-05 Procédé de préparation d'un vaccin contre la maladie de Carré.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB30150/59A GB931137A (en) 1959-09-03 1959-09-03 A method of producing canine distemper vaccine

Publications (1)

Publication Number Publication Date
GB931137A true GB931137A (en) 1963-07-10

Family

ID=10303107

Family Applications (1)

Application Number Title Priority Date Filing Date
GB30150/59A Expired GB931137A (en) 1959-09-03 1959-09-03 A method of producing canine distemper vaccine

Country Status (4)

Country Link
BE (1) BE594749A (de)
CH (1) CH402283A (de)
GB (1) GB931137A (de)
LU (1) LU39127A1 (de)

Also Published As

Publication number Publication date
LU39127A1 (de) 1960-11-03
BE594749A (fr) 1961-03-06
CH402283A (de) 1965-11-15

Similar Documents

Publication Publication Date Title
Madin et al. Isolation of the infectious bovine rhinotracheitis virus
Rockborn Canine distemper virus in tissue culture
Zinsser et al. A study of rickettsiae grown on agar tissue cultures
Preston Arthritis in rats caused by pleuropneumonia-like micro-organisms and the relationship of similar organisms to human rheumatism
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
GB1177635A (en) Cell Stains.
Magill et al. Studies with human influenza virus cultivated in artificial medium
US3080291A (en) Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom
US4571386A (en) Feline infectious peritonitis vaccine
US4169761A (en) Process for the cultivation of viruses
GB1000907A (en) Attenuated live measles virus vaccine and method of production
Laufs Immunisation of marmoset monkeys with a killed oncogenic herpesvirus
GB931137A (en) A method of producing canine distemper vaccine
Wood et al. Cultivation of Poliomyelitis Virus in Tissue Culture III. Synthetic Medium in Roller Tube Cultures.
EP0011865B1 (de) Impfstoff gegen infektiöse Peritonitis der Feliden und Verfahren zu seiner Herstellung
US3057783A (en) Infectious bovine rhinotracheitis vaccine and method of preparing it
US3725542A (en) Intramuscular vaccination program and vaccine against rhinopneumonitis and process for preparing it
Melendez et al. Multiplication of foot and mouth disease virus in adult kidney, and embryonic lung and heart bovine tissue cultures
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
GB878704A (en) Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom
PT72015B (en) Process for preparing "invitro" cultures of hepatitis b virus
FR2290220A2 (fr) Nouveau vaccin antirabique
GB896446A (en) Production of improved virus vaccine for canine distemper
GB1070764A (en) Improvements in or relating to a process for culturing tissue cells
DE1030516B (de) Naehrboden zur Viruszuechtung